Published 2020
| Version v1
Publication
Exploiting Sphingo- and Glycerophospholipid Impairment to Select Effective Drugs and Biomarkers for CMT1A
Additional details
- URL
- http://hdl.handle.net/11567/1024938
- URN
- urn:oai:iris.unige.it:11567/1024938
- Origin repository
- UNIGE